CX3CL1 and neoplasm: It has nevertheless to be noted that in our mouse models, FKN expression is a major driving force of anti‐tumor activities, causing a very highly significant delay (P < 0.0001) in tumor growth (Fig 4B) associated with a very significant (P = 0.001) increase in median survival from 20 to 35 days (Fig 4C).